Bio-Rad Laboratories Inc (BIO)
343.70
+6.61
(+1.96%)
USD |
NYSE |
Oct 04, 16:00
343.80
+0.10
(+0.03%)
After-Hours: 20:00
Bio-Rad Laboratories Shareholders Equity (Annual): 8.741B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 8.741B |
December 31, 2022 | 9.615B |
December 31, 2021 | 13.69B |
December 31, 2020 | 9.880B |
December 31, 2019 | 5.755B |
December 31, 2018 | 4.020B |
December 31, 2017 | 2.930B |
December 31, 2016 | 2.579B |
December 31, 2015 | 2.491B |
December 31, 2014 | 2.185B |
December 31, 2013 | 2.187B |
December 31, 2012 | 2.015B |
December 31, 2011 | 1.744B |
December 31, 2010 | 1.537B |
December 31, 2009 | 1.260B |
December 31, 2008 | 1.041B |
December 31, 2007 | 971.69M |
December 31, 2006 | 819.54M |
December 31, 2005 | 657.97M |
December 31, 2004 | 596.89M |
Date | Value |
---|---|
December 31, 2003 | 495.81M |
December 31, 2002 | 383.09M |
December 31, 2001 | 283.88M |
December 31, 2000 | 244.62M |
December 31, 1999 | 220.10M |
December 31, 1998 | 214.30M |
December 31, 1997 | 196.70M |
December 31, 1996 | 183.50M |
December 31, 1995 | 157.10M |
December 31, 1994 | 129.80M |
December 31, 1993 | 110.30M |
December 31, 1992 | 107.10M |
December 31, 1991 | 90.80M |
December 31, 1990 | 81.10M |
December 31, 1989 | 68.90M |
December 31, 1988 | 59.50M |
December 31, 1987 | 50.10M |
December 31, 1986 | 43.30M |
December 31, 1985 | 29.90M |
December 31, 1984 | 18.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
5.755B
Minimum
2019
13.69B
Maximum
2021
9.535B
Average
9.615B
Median
2022
Shareholders Equity (Annual) Benchmarks
Agilent Technologies Inc | 5.845B |
Bruker Corp | 1.377B |
Avantor Inc | 5.253B |
Azenta Inc | 2.534B |
Harvard Bioscience Inc | 73.07M |